TD Cowen raises Iovance Biotherapeutics price target on revenue outlook
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Iovance rises as 2026 revenue outlook tops analyst consensus seekingalpha.com